Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Deferred Revenue
$1.68M
Quarterly · Period ending: · USD
LCTX Deferred Revenue
Latest reported$1.68Mperiod ending
Latest reported$1.68Mperiod ending
LCTX Quarterly Deferred Revenue ($0.00 → $1.68M)
Quarterly deferred revenue
High-resolution chart · PNG
LCTX deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 1,678,000 | |
| 1,716,000 | |
| 3,333,000 | |
| 3,766,000 | |
| 5,257,000 | |
| 6,931,000 | |
| 7,388,000 | |
| 8,250,000 | |
| 9,142,000 | |
| 10,106,000 | |
| 10,808,000 | |
| 9,915,000 | |
| 10,379,000 | |
| 11,009,000 | |
| 9,421,000 | |
| 12,364,000 | |
| 15,785,000 | |
| 14,885,000 | |
| 18,119,000 | |
| 975,000 | |
| 613,000 | |
| 101,000 | |
| 193,000 | |
| 46,000 | |
| 297,000 | |
| 408,000 | |
| 45,000 | |
| 182,000 | |
| 44,000 | |
| 43,000 | |
| 42,000 | |
| 120,000 | |
| 470,000 | |
| 765,000 | |
| 797,000 | |
| 513,000 | |
| 621,000 | |
| 679,000 | |
| 572,000 | |
| 537,000 | |
| 627,000 | |
| 2,878,000 | |
| 2,952,000 | |
| 2,147,000 | |
| 2,292,000 | |
| 1,652,846 | |
| 208,357 | |
| 177,574 | |
| 270,348 | |
| 177,594 | |
| 235,276 | |
| 397,198 | |
| 462,773 | |
| 394,343 | |
| 400,870 | |
| 410,413 | |
| 476,217 | |
| 463,322 | |
| 465,544 | |
| 471,107 | |
| 507,688 | |
| 482,650 | |
| 550,083 | |
| 587,220 | |
| 586,978 | |
| 623,736 | |
| 367,904 | |
| 292,904 | |
| 306,104 | |
| 312,904 | |
| 312,904 | |
| 1,576,574 | |
| 293,070 | |
| 286,555 | |
| 261,091 | |
| 193,633 | |
| 189,507 | |
| 185,738 | |
| 183,935 | |
| 182,242 | |
| 182,131 | |
| 141,375 | |
| 140,000 | |
| 529,375 | |
| 553,438 | |
| 0 | |
| 901,563 | |
| 624,514 | |
| 679,688 | |
| 393,750 | |
| 407,813 | |
| 421,875 | |
| 435,938 | |
| 450,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |